Insights

Expanding Leadership LEO Pharma is strengthening its medical dermatology leadership with the upcoming appointment of a chief development officer, indicating an opportunity to offer tailored solutions to support their leadership and innovation initiatives.

Innovative Pipeline The recent development of promising therapies like temtokibart for atopic dermatitis and Spevigo for pustular psoriasis highlights potential demand for advanced dermatological treatments, presenting sales opportunities for complementary or supporting products.

Strategic Partnerships Collaborations with firms like Boehringer Ingelheim and Oxcia AB show LEO Pharma's openness to partnerships, creating avenues to introduce innovative solutions or services that can enhance their R&D and commercialization efforts.

Market Engagement Active participation in global dermatology conferences and unveiling clinical trial data indicates a strong focus on market visibility, providing opportunities to collaborate on educational, marketing, or patient engagement platforms.

Financial Growth With revenues exceeding 1 billion dollars and significant funding, LEO Pharma's financial strength suggests readiness for investing in scalable commercial solutions, digital transformation, or expanding their pipeline through strategic purchases or partnerships.

LEO Pharma Tech Stack

LEO Pharma uses 8 technology products and services including GDPR, HashiCorp Terraform, DBT, and more. Explore LEO Pharma's tech stack below.

  • GDPR
    Certificates
  • HashiCorp Terraform
    Configuration Management
  • DBT
    Continuous Integration
  • Monte Carlo
    Data Management Platforms
  • Microsoft Outlook
    Email
  • JSON-LD
    Javascript Frameworks
  • Node.js
    Programming Languages
  • Timesheets
    Time Tracking

Media & News

LEO Pharma's Email Address Formats

LEO Pharma uses at least 1 format(s):
LEO Pharma Email FormatsExamplePercentage
First.Last@leo-pharma.comJohn.Doe@leo-pharma.com
92%
FLast@leo-pharma.comJDoe@leo-pharma.com
7%
F.Last@leo-pharma.comJ.Doe@leo-pharma.com
1%

Frequently Asked Questions

Where is LEO Pharma's headquarters located?

Minus sign iconPlus sign icon
LEO Pharma's main headquarters is located at Industriparken 55, Ballerup, DK 2750, DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is LEO Pharma's phone number?

Minus sign iconPlus sign icon
You can contact LEO Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is LEO Pharma's official website and social media links?

Minus sign iconPlus sign icon
LEO Pharma's official website is leo-pharma.com and has social profiles on LinkedInCrunchbase.

How much revenue does LEO Pharma generate?

Minus sign iconPlus sign icon
As of October 2025, LEO Pharma's annual revenue is estimated to be $5B.

What is LEO Pharma's NAICS code?

Minus sign iconPlus sign icon
LEO Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does LEO Pharma have currently?

Minus sign iconPlus sign icon
As of October 2025, LEO Pharma has approximately 5.2K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: R. C.Chief Scientific Officer And Executive Vice President: J. P. T.Chief Information Security Officer: W. P.. Explore LEO Pharma's employee directory with LeadIQ.

What industry does LEO Pharma belong to?

Minus sign iconPlus sign icon
LEO Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does LEO Pharma use?

Minus sign iconPlus sign icon
LEO Pharma's tech stack includes GDPRHashiCorp TerraformDBTMonte CarloMicrosoft OutlookJSON-LDNode.jsTimesheets.

What is LEO Pharma's email format?

Minus sign iconPlus sign icon
LEO Pharma's email format typically follows the pattern of First.Last@leo-pharma.com. Find more LEO Pharma email formats with LeadIQ.

How much funding has LEO Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2025, LEO Pharma has raised $533M in funding. The last funding round occurred on Mar 23, 2021 for $533M.

When was LEO Pharma founded?

Minus sign iconPlus sign icon
LEO Pharma was founded in 1908.
LEO Pharma

LEO Pharma

Pharmaceutical ManufacturingDenmark5001-10000 Employees

LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark with a global team of 4,200 people, serving millions of patients across the world. In 2023, the company generated net sales of DKK 11.4 billion.

Disclaimer:
This site is intended for discussions about LEO Pharma and the various initiatives LEO Pharma is involved in. Due to regulations, discussions about pharmaceutical products are not allowed on this site. All content must be factual and non-promotional.

LEO Pharma reserves the right to moderate or remove any content that may be inconsistent with legislation, industry ethics and regulations and LEO Pharma’s values, including:

- profane or vulgar language
- insulting or offensive comments, such as displays of racism, calls to violence, hate propaganda, etc.
- commercial or political advertising
- copyright infringements, or any violation of the rights of external parties
- automatically-generated content i.e. spam
- wrong/false statements

For more information about our social media principles, please visit https://www.leo-pharma.com/social-media-principles

Section iconCompany Overview

Headquarters
Industriparken 55, Ballerup, DK 2750, DK
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1908
Employees
5001-10000

Section iconFunding & Financials

  • $533M

    LEO Pharma has raised a total of $533M of funding over 1 rounds. Their latest funding round was raised on Mar 23, 2021 in the amount of $533M.

  • $1B$10B

    LEO Pharma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $533M

    LEO Pharma has raised a total of $533M of funding over 1 rounds. Their latest funding round was raised on Mar 23, 2021 in the amount of $533M.

  • $1B$10B

    LEO Pharma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.